logo

Last Update

This profile was last updated on 12/29/2015 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Chester Stock?

Chester Stock

Scientific Director for Cancer Research

Sloan Kettering's

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Sloan Kettering's

Web References(19 Total References)


"Second Opinion": Laetrile Scandal at Sloan-Kettering Revisited | Talk In New York

www.talkinnewyork.com [cached]

In fact, on July 2nd 1974 the top leaders of Sloan-Kettering (Lewis Thomas, Robert Good, Chester Stock and Lloyd Old) visited with the NCI and FDA in a large meeting to persuade them to allow clinical trials, and it was agreed to consider trials to treat cancer and relieve pain, and "the FDA will publicly endorse good research on amygdalin as in the public interest."
Chester Stock, director of the Sloan-Kettering's Walker labs told the press "We have found Laetrile negative in all the animal systems we have tested.


Has B17 been tested by Modern Medicine?

www.b17.com.au [cached]

Dr Chester Stock, the Head of Sloan Kettering's laboratory-testing division even wrote:
"Few if any names in cancer research are as widely known as Kanematsu Segiura's....Possibly the highest regard in which his work is held is best characterised by a comment made to me by a visiting investigator in cancer research from Russia. He said "when Segiura publishes, we know we do not have to repeat the study, for we would obtain the same results he has reported"'. The same Doctor Chester Stock who had praised Segiura's work took the microphone and began describing the finer details of the testing.


www.essiac-tea.org

The secret ingredient of Essiac tea was discovered by Sheila Snow who obtained letters from Dr. Chester Stock of the Memorial Sloan-Kettering Cancer Center.
1. [April 4, 1974 letter to Dr. Chester Stock; Ref. ESSIAC, THE SECRETS OF RENE CAISSE'S HERBAL PHARMACY, p. 28] 2. [January 1975 letter to Dr. Chester Stock; Ref. ESSIAC, THE SECRETS OF RENE CAISSE'S HERBAL PHARMACY, p. 30] 3. [August 4, 1975 letter to Dr. Chester Stock; Ref. ESSIAC, THE SECRETS OF RENE CAISSE'S HERBAL PHARMACY, p. 31] 4. [June 14, 1976 letter to Dr. Chester Stock; Ref. THE ESSIAC BOOK, p. 123]


Essiac is not Brusch spelled backwards

renecaissetea.com [cached]

Rene Caisse was adamant about the importance of using the whole Sheep sorrel herb including the roots, as evidenced by her hand-written letter to Dr. Chester Stock of the Memorial Sloan-Kettering Cancer Research Center in 1976.


www.essiac-tea.org

This information was discovered by Sheila Snow who obtained letters from Dr. Chester Stock of the Memorial Sloan-Kettering Cancer Center.
Dr. Stock was testing sheep sorrel solution by injecting it into mice. The letters between Dr. Stock and Rene Caisse are part of this Essiac archive collection and can be seen in the appendix of THE ESSIAC BOOK by Mali Klein.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory